NR2C2 and neoplasm: TR4 is overexpressed in corticotroph adenomas and corticotroph tumor cell lines and activatesPOMC by binding to its promoter, an effect that is enhanced by phosphorylation of TR4 through the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) pathway.